Official websites use .gov A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Captopril: Evaluation of Low Doses, Twice-Daily Doses and the Addition of Diuretic for the Treatment of Mild to Moderate Hypertension
Captopril: Evaluation of Low Doses, Twice-Daily Doses and the Addition of Diuretic for the Treatment of Mild to Moderate Hypertension
Contributor(s):
Veterans Administration Cooperative Study Group on Antihypertensive Agents Clinical Science
In the early 1980s, a new class of drugs were developed that treated hypertension by preventing the synthesis of certain hormones that caused blood vessels to constrict. These drugs, of which Captopril was one, were designated as angiotensin converting enzyme (ACE) inhibitors. Freis's team reported that Captopril, which up to then had only been administered to the most severe hypertensive patients, effectively reduced blood pressure in lower doses than indicated in previous studies, reducing the likelihood of deleterious side effects. As a result, they recommended that its use be extended to the general population.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)